Melanoma News

• WCM-EADO 2025 Harnessing the Microbiome to Treat Melanoma: Can It Work? Researchers are exploring strategies to alter the gut microbiome to improve patients’ responses to immunotherapy. New research provide encouraging, but very early, data.
  Medscape Medical News, April 10, 2025
• WCM-EADO 2025 Is Drug Holiday Safe in Metastatic Melanoma? Good response rates were seen even after immunotherapy re-initiation following a drug holiday.
  Medscape Medical News, April 09, 2025
• WCM-EADO 2025 Confirmed Benefit of Adjuvant Therapy in Stage III Melanoma Real-world data show that adjuvant therapy, not complete nodal dissection, is crucial for preventing relapse in patients with stage III melanoma.
  Medscape Medical News, April 09, 2025
• WCM-EADO 2025 Rising Skin Cancer Rates: Epidemic or Overdiagnosis? While skin cancer rates are growing in many parts of the world, experts disagree on whether this represents a true epidemic or overdiagnosis is a contributing factor.
  Medscape Medical News, April 09, 2025
• WCM-EADO 2025 Melanoma’s Hidden Toll in Skin of Color Although melanoma primarily affects fair-skinned people, people with darker skin are also at risk but often go undiagnosed until the cancer has become more advanced.
  Medscape Medical News, April 08, 2025
• 3D TBP for Melanoma: More Excisions, No Clear Benefit A study finds that 3D total-body photography increases excisions in high-risk patients but fails to improve melanoma detection or cost-effectiveness.
  Medscape Medical News, April 08, 2025
• Do Low-Grade Toxicities Affect Melanoma Treatment Success? The burden of low-grade toxicity is clinically significant in patients treated with adjuvant pembrolizumab for stage III melanoma.
  Medscape Medical News, April 08, 2025
• WCM-EADO 2025 Assay Shows Promise for Early Melanoma Risk Stratification The Merlin assay may help identify patients who can forgo sentinel lymph node biopsy.
  Medscape Medical News, April 07, 2025
• WCM-EADO 2025 Population vs Tailored Skin Cancer Screening: Which Is Best? Broad-based skin cancer screening may strain healthcare resources and lead to overdiagnosis, but it may also help catch more skin cancers earlier. Experts debate the pros and cons.
  Medscape Medical News, April 04, 2025
• How Cancer Cells Travel to New Tissues and Take Hold Understanding these astonishing migrations through the human body, known as metastases, could suggest novel treatments.
  Knowable Magazine, April 01, 2025
• AAD 2025 Study: 3D Total-body Imaging Improves Biopsy ‘Hit’ Rates Automated three-dimensional total-body photography improves the efficiency of positive malignant biopsies and reduces unnecessary biopsies of skin lesions, a study showed.
  Medscape Medical News, March 21, 2025
• Mohs Surgery Shows Superior Outcomes in Hand, Foot Melanoma Mohs micrographic surgery tops conventional excision for hand and foot melanomas by reducing rates of reconstruction with positive margins, repeat surgeries, and time to definitive reconstruction.
  Medscape Medical News, March 14, 2025
• AAD 2025 AI-Based Skin Cancer Screen Effective in Real World Dermatoscope imaging processed with AI has been in use in the UK for 4 years with accuracy shown to be at least equal to expert evaluation, leading to other advantages for the hospital system.
  Medscape Medical News, March 12, 2025
• 1 in 5 Patients Report Skin Toxicity With Melanoma Rx Over 20% of patients with advanced melanoma who were treated with nivolumab/relatlimab combination therapy experience skin toxicity, but no cases require treatment discontinuation.
  Medscape Medical News, March 04, 2025
• Tick Tock: Is Immunotherapy More Effective Earlier in Day? The time of day of immunotherapy infusions does appear to affect patient outcomes. But convincing the wider oncology community may be a hard sell.
  Medscape Medical News, February 28, 2025
• Immunotherapy Reduces Skin Cancer Precursors A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing cancer treatment.
  Medscape Medical News, February 12, 2025
• Promise for CAR T-Cell Therapies in Solid Tumors? CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in targeting solid tumors have been limited.
  Medscape Medical News, February 10, 2025
• Advances in Systemic Treatments for Melanoma Highlighted “Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” said Kathryn Bollin, MD.
  Medscape Medical News, February 07, 2025
• Expert Tips on Mohs Surgery for Melanoma Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the literature.
  Medscape Medical News, February 06, 2025
• ‘Cure’ in Cancer: Should Oncologists Use the Word? Despite advances in treatments and improvements in survival overall, many oncologists remain hesitant to tell patients they’re cured.
  Medscape Medical News, February 04, 2025